arrow
M

Masahiro Umeda

Meiji University of Integrative Medicine
H指数:44
被引数:7,736

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recurrent Myelin Oligodendrocyte Glycoprotein Antibody-Positive Aseptic Meningitis at the Identical Site in a Child: Leptomeningeal Enhancement Detected by Contrast-Enhanced FLAIR Imaging

复发性髓鞘少突胶质细胞糖蛋白抗体阳性无菌性脑膜炎在儿童相同部位的复发:对比增强FLAIR成像检测到的软脑膜强化

2026-05-010
PRE
T4a classification for oral cancer using mandibular canal invasion instead of bone marrow invasion in the TNM staging system

使用下颌管侵犯而非骨髓侵犯的T4a分类对口腔癌进行TNM分期

2025-11-110
OAAI
Multi-institutional observational study on the relationship between oral infection focus and surgical site infection in artificial arthroplasty and the clinical significance of tooth extraction: An analysis using propensity score matching

多中心观察性研究:口腔感染灶与人工关节置换术后手术部位感染的关系及拔牙的临床意义——基于倾向性评分匹配的分析

2025-08-090
OAAI
Potential relationship among CT and MRI imaging, histological findings, and treatment outcomes in patients with medication-related osteonecrosis of the jaw undergoing segmental mandibulectomy–A retrospectives study

CT和MRI影像、组织学发现与接受节段性下颌骨切除术的药物相关性颌骨坏死患者治疗结局之间的潜在关系——一项回顾性研究

2024-12-280
OAAI
EFFICACY AND SAFETY OF A DEXAMETHASONE-BASED MOUTHWASH TO PREVENT CHEMOTHERAPY-INDUCED STOMATITIS IN WOMEN WITH BREAST CANCER: A MULTICENTRE, OPEN-LABEL, RANDOMISED PHASE 2 STUDY (vol 23, 101896, 2023)

一项关于地塞米松口腔漱口液预防乳腺癌女性化疗诱导性口腔炎的疗效与安全性研究:一项多中心、开放标签、随机第2阶段研究(vol 23, 101896, 2023)

2024-12-010
PRE
Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan

日本不可切除或复发/转移性口腔癌的分子靶向药物和免疫检查点抑制剂的疗效和安全性

2024-07-010
OAAI